CTOs on the Move

CardioNet, Inc.

www.cardionet.com

 
CardioNet, Inc. (CardioNet), provides continuous, real-time ambulatory outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health.
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million
  • www.cardionet.com
  • 227 Washington St Ste 300
    Conshohocken, PA USA 19428-2086
  • Phone: 610.729.7000

Executives

Name Title Contact Details

Similar Companies

Ascension

Ascension is a faith-based healthcare organization dedicated to providing compassionate, personalized care to all, with special attention to persons living in poverty and those most vulnerable. They operate 2,500 sites of care across 24 states and the ...

The Female Health Company

The Female Health Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northwestern University Clinical andTranslational Sciences Institute (NUCATS)

NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.

Pacific Reproductive Svc

Pacific Reproductive Svc is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SpectraScience

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.